<div id="readability-page-1"><p>Tilly's (NYSE:TLYS - Get Free Report) issued an update on its fourth quarter 2025 earnings guidance on Wednesday morning. The company provided earnings per share guidance of -0.190--0.120 for the period, compared to the consensus earnings per share estimate of -0.320. The company issued revenue guidance of $146.0 million-$151.0 million, compared to the consensus revenue estimate of $146.1 million.</p><h2>Analyst Upgrades and Downgrades</h2><ul><li>Three Mall Retailers For Your Reopening Watchlist</li></ul><p>Several brokerages have recently issued reports on TLYS. Roth Capital  reissued a &#34;neutral&#34; rating on shares of Tilly's in a research report on Thursday, September 4th. Weiss Ratings  reaffirmed a &#34;sell (d-)&#34; rating on shares of Tilly's in a research note on Monday. Finally, Zacks Research cut Tilly's from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a report on Tuesday, November 18th. Four research analysts have rated the stock with a Hold rating and one  has given a Sell rating to the stock. Based on data from MarketBeat.com, the company  has a consensus rating of &#34;Reduce&#34; and a consensus target price of $2.25.</p><p><b>Get Our Latest Analysis on Tilly's</b></p><h2>Tilly's Stock Up 20.7%</h2><ul><li>Betting On Tilly’s Inc <span>NYSE: TLYS<span></span></span> 12% Yield</li></ul><p>TLYS traded up $0.31 during trading hours on Wednesday, hitting $1.78. 4,399,580 shares of the company's stock were exchanged, compared to its average volume of 275,479. The stock has a market cap of $54.08 million, a price-to-earnings ratio of -1.17 and a beta of 1.14. Tilly's has a 1-year low of $0.57 and a 1-year high of $4.75. The stock's 50-day moving average is $1.58 and its two-hundred day moving average is $1.55. </p><p>Tilly's (NYSE:TLYS - Get Free Report) last issued its quarterly earnings results on Wednesday, December 3rd. The specialty retailer reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.30) by $0.25. The firm had revenue of $139.59 million for the quarter, compared to analysts' expectations of $136.90 million. Tilly's had a negative net margin of 8.28% and a negative return on equity of 48.33%. During the same period in the previous year, the firm posted ($0.43) EPS. Tilly's has set its Q4 2025 guidance at -0.190--0.120 EPS.  On average, equities research analysts anticipate that  Tilly's will post -1.08 EPS for the current year. </p><h2>Institutional Trading of Tilly's</h2><p>A number of large investors have recently added to or reduced their stakes in the company. Qube Research &amp; Technologies Ltd bought a new stake in shares of  Tilly's during the 2nd quarter worth about $27,000.  Corient Private Wealth LLC acquired a new stake in  Tilly's during the second quarter worth approximately $48,000.  Marshall Wace LLP bought a new stake in shares of  Tilly's during the second quarter worth approximately $70,000.  Bank of America Corp DE boosted its holdings in shares of  Tilly's by 31.4% during the fourth quarter. Bank of America Corp DE now owns 17,566 shares of the specialty retailer's stock worth $75,000 after acquiring an additional 4,193 shares during the period.  Finally, CIBC Bancorp USA Inc. acquired a new position in shares of  Tilly's in the third quarter valued at approximately $82,000. Institutional investors and hedge funds own  76.38% of the company's stock. </p><h2>Tilly's Company Profile</h2> (Get Free Report)<p>Tilly's, Inc engages in the retail of casual apparel, footwear, and accessories. Its stores are located in retail centers, including malls, lifestyle centers, power centers, community centers, outlet centers, and street-front locations. The company was founded by Hezy Shaked and Tilly Levine in 1982 and is headquartered in Irvine, CA.</p><h2>See Also</h2><ul><li>Five stocks we like better than Tilly's</li><li>Financial Services Stocks Investing</li><li>3 Stocks You’ll Wish You Bought Before 2026</li><li>What Are Dividend Challengers?</li><li>Wall Street Punished CrowdStrike for Beating Earnings? Seriously?</li><li>Health Care Stocks Explained: Why You Might Want to Invest</li><li>Okta: Excuses to Sell Vs. Reasons to Buy</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRMWVM?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="325" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRMWVM"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Tilly's Right Now?</h2><p>Before you consider Tilly's, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilly's wasn't on the list.</p><p>While Tilly's currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

TLYS

<p>Tilly's (NYSE:TLYS) updated its Q4 2025 earnings guidance, projecting EPS between -0.190 and -0.120, better than the consensus estimate of -0.320. Revenue guidance is set between $146.0 million and $151.0 million, slightly above the consensus of $146.1 million. The stock rose 20.7% to $1.78, with a market cap of $54.08 million. Analysts have a consensus 'Reduce' rating with a target price of $2.25. Institutional investors own 76.38% of the stock.</p>

Tilly's (NYSE:TLYS) Releases Q4 2025 Earnings Guidance